The Cardiology Sale That Revealed How PE Really Operates
Dr. Patel had built an impressive cardiology practice over 18 years. Four cardiologists, two cath labs, owned ASC, and $6.2 million in annual revenue. When a PE-backed platform approached with a $21 million offer-roughly 12x his adjusted EBITDA-he assumed he'd hit the jackpot.
Six months after closing, he called me. Not to celebrate, but to understand what had happened.
The $21 million headline had translated to $12.4 million cash at closing. The rest was split: $4.2 million in a three-year earnout tied to EBITDA targets, and $4.4 million "rolled" into equity in the acquiring platform.
The earnout problem
The PE firm centralized billing operations post-close. Collections dropped 8% during the transition. Add in new corporate overhead allocations, and Dr. Patel hit only 71% of his first-year EBITDA target-triggering the earnout's cliff provision. He received nothing for year one.
The rollover problem
The platform's third-year EBITDA projections, which justified the valuation of his rollover equity, assumed 22% annual growth through add-on acquisitions. Two years in, they'd acquired half the practices projected. His $4.4 million rollover was now worth approximately $2.8 million on paper-if there was ever a buyer for the platform.
The "$21 million deal" netted him approximately $15.2 million-and that assumes his rollover eventually converts to cash. His effective multiple wasn't 12x. It was closer to 8.7x. Still a good outcome, but not what the LOI promised.
I'm an M&A attorney who has represented physicians in practice sales to PE platforms, health systems, and management services organizations. I don't broker deals. I don't take commission on sale prices. What follows is what I tell my physician clients: the unfiltered reality of selling your practice in 2026.
The 2026 PE Landscape for Physician Practices
Medical practice M&A market conditions in 2026 reflect a recalibration from peak 2021-2023 valuations, with EBITDA multiples ranging from 3-15x depending on specialty, ancillary services (ASCs, imaging, pathology), practice size, and physician commitment length. The median healthcare services multiple is approximately 11.5x.
Physician practice M&A remains active despite the post-2021 normalization. What's changed is buyer sophistication and the death of "easy" deals.
During 2021-2023, abundant capital and low interest rates created a feeding frenzy. PE firms launched specialty-specific platforms across cardiology, GI, ophthalmology, dermatology, and more. Competition for quality practices pushed multiples to historic highs.
2024-2025 brought recalibration. Higher rates made leverage more expensive. Some platforms struggled to integrate acquisitions. The median healthcare services EV/EBITDA multiple dropped from 14.5x in 2024 to approximately 11.5x in 2025.
Current Multiples by Practice Size
| Practice Size | EBITDA Multiple | Typical Buyers |
|---|---|---|
| Small (<$500K EBITDA) | 3-6x | Individual physicians, small groups |
| Mid-Size ($500K-$2M EBITDA) | 5-10x | PE add-ons, regional groups |
| Large ($2M-$5M EBITDA) | 8-12x | PE platforms, health systems |
| Platform (>$5M EBITDA) | 10-15x | PE platforms seeking scale |
Hot Specialties for PE in 2026
Not all specialties receive equal attention. PE buyers focus on specialties with:
- Strong ancillary revenue potential (ASCs, imaging, lab)
- Recurring patient relationships
- Fragmented markets ripe for consolidation
- Favorable reimbursement trends
Highest Competition:
- Cardiology
- Gastroenterology
- Ophthalmology (retina)
Strong Activity:
- Dermatology
- Orthopedics
- Pain Management
Growing Interest:
- Urology
- Women's Health
- Oncology
The Ancillary Premium
Owned ancillaries-ASCs, imaging centers, pathology labs, cath labs-are the single biggest value driver in physician practice sales. They can add 1-3 multiple turns to your valuation.
Why ancillaries matter: PE buyers model EBITDA expansion through ancillary development. A practice that already owns these assets is de-risked. The revenue is already flowing; the buyer just needs to optimize it.
A GI practice with $1.5M EBITDA from professional services alone might trade at 7-8x. The same practice with an owned ASC generating an additional $800K in distributions might trade at 10-12x on the combined $2.3M.
Specialty matters more than size in 2026 physician practice M&A. Cardiology, GI, and ophthalmology practices with owned ancillaries (ASCs, imaging, pathology) command 10-15x EBITDA; practices without ancillaries sell for 3-8x regardless of specialty.
Medical Practice Valuation: What Your Practice Is Actually Worth
Medical practice valuation methodology uses adjusted EBITDA as the basis for determining purchase price. Key adjustments include owner compensation above market rate (benchmarked against MGMA data), non-recurring expenses, and normalization for related-party transactions. Stark Law and Anti-Kickback constraints require that post-sale physician compensation be at fair market value.
Physician practice valuation centers on EBITDA, but the calculation is more complex than other professional services because of regulatory constraints (Stark, Anti-Kickback) and the unique interplay between professional services and ancillary operations.
The EBITDA Calculation
Net Income
+ Interest Expense
+ Taxes
+ Depreciation
+ Amortization
+ Owner Compensation Above Market (varies by specialty)
+ Non-recurring Expenses
+ Personal Expenses Through Practice
± Normalization for related-party transactions
= Adjusted EBITDA
The physician comp adjustment: This is where arguments happen. Replacement physician compensation varies by specialty, geography, and call coverage. Buyers use MGMA or Sullivan Cotter data. Sellers often argue their compensation reflects above-market productivity.
The FMV constraint: Because of Stark and Anti-Kickback, any compensation paid to physicians post-sale must be at fair market value. PE buyers can't simply pay you above-market salary to make the economics work. This limits deal structuring options compared to non-healthcare transactions.
Value Drivers and Detractors
What Adds Value (+1-3x)
- Owned ASC, imaging, pathology
- Younger physicians on long-term contracts
- Multi-site footprint
- Diversified payor mix
- Value-based care contracts
- Strong referral relationships
- Mature revenue cycle management
- EHR/PM systems with clean data
What Reduces Value (-1-3x)
- Physicians nearing retirement
- Heavy Medicare/Medicaid reliance
- Single-physician practice
- No ancillary revenue
- Unclear or non-GAAP financials
- Pending compliance issues
- Malpractice claims history
- Key physician flight risk
The Age Premium/Discount
Physician age and commitment length materially impact valuation. PE buyers model a 5-7 year hold period. They need physicians to stay.
- Younger physicians (<50) with 5+ year commitments: +1-2x premium
- Mid-career (50-60) with 3-5 year commitments: Standard multiple
- Retirement-age (>60) with <3 year commitment: -1-2x discount
This creates a tension: The physicians who built the practice and want to exit may be the ones whose departure risk reduces the valuation.
Physician age and commitment length drive 1-2x multiple swings in either direction. Practices with younger physicians on long-term contracts command premiums; practices with retirement-age physicians who won't commit to 3+ years see discounts that often surprise sellers.
Who's Buying: PE Platforms, Health Systems, and MSOs
Buyer types for physician practice sales include PE platforms (8-15x EBITDA, require 15-40% rollover equity), health systems (5-8x, typically all-cash), and management services organizations (7-12x, MSO structure for CPOM compliance). Each buyer type offers different trade-offs between valuation, clinical autonomy, and post-sale complexity.
Understanding buyer motivations and constraints helps you negotiate better. Each buyer type has different priorities, capital structures, and deal approaches.
Private Equity Platforms
What they want: A foundation to build a large specialty-specific enterprise. They'll acquire your practice, install management infrastructure, add smaller practices ("add-ons"), develop ancillaries, and exit in 3-7 years to a larger PE firm or strategic buyer.
Typical offer: 8-15x EBITDA depending on specialty and ancillary mix. Require 15-40% rollover equity. Earnouts tied to EBITDA growth. Employment agreements of 3-5 years.
The PE playbook: They underwrite assuming 15-20% annual EBITDA growth through:
- Add-on acquisitions at lower multiples
- Ancillary service development
- Revenue cycle optimization (200-300 bps margin improvement)
- Shared services (HR, IT, purchasing leverage)
Health Systems
What they want: Referral capture, service line development, and geographic coverage. Hospital-employed physicians refer within the system.
Typical offer: 5-8x EBITDA. All-cash deals more common (no rollover). Employment under hospital compensation structures. Non-competes tied to hospital geography.
The trade-off: Health system deals often offer lower multiples but simpler structures. No rollover risk. No earnout complexity. But you become a hospital employee with all that entails-productivity expectations, administrative oversight, EHR mandates.
Management Services Organizations (MSOs)
What they want: To provide management services to physician practices while navigating corporate practice of medicine restrictions. MSOs can't employ physicians directly in many states, so they acquire the "non-clinical" business assets.
Typical offer: Similar to PE (7-12x) since most MSOs have PE backing. Structure involves selling practice assets to MSO while maintaining a separate professional corporation for clinical operations.
The complexity: MSO deals require careful structuring to comply with state CPOM laws. The management services agreement between your professional corporation and the MSO becomes critical-it defines your ongoing economics.
Buyer Comparison
| Factor | PE Platform | Health System | MSO |
|---|---|---|---|
| Typical Multiple | 8-15x | 5-8x | 7-12x |
| Cash at Close | 60-85% | 90-100% | 60-80% |
| Rollover Required | Yes (15-40%) | Rarely | Often (15-30%) |
| Clinical Autonomy | Moderate | Lower | Higher |
| Deal Complexity | High | Moderate | High |
Health systems pay lower multiples (5-8x) but offer simpler, mostly-cash deals. PE platforms pay higher multiples (8-15x) but require rollover equity that ties your returns to their execution. Match buyer type to your risk tolerance and post-sale priorities.
Deal Structure: Cash, Rollover, and the Hidden Economics
Physician practice deal structure typically includes cash at closing (60-85%), rollover equity (15-40% retained in the acquiring platform), earnouts (0-20% contingent on post-close performance over 1-3 years), and working capital adjustments settled 60-90 days post-close. The structure determines actual proceeds-headline numbers often overstate what sellers actually receive.
A $20 million offer isn't $20 million. The structure determines what you actually receive-and when. I've seen physicians ecstatic over headline numbers who later realized their effective proceeds were 30% lower.
Components of a PE Offer
Every PE offer breaks down into:
- Cash at closing: Typically 60-85% of headline price
- Rollover equity: 15-40% retained as ownership in the platform
- Earnout: 0-20% contingent on post-close performance
- Working capital adjustment: Settled 60-90 days post-close
Rollover Equity: The Second Bite (Maybe)
PE firms require rollover for two reasons: (1) it aligns your incentives with their success, and (2) it signals you believe in the platform's future.
How rollover can work in your favor: The PE firm acquires your practice at 10x, builds a platform, and sells in 5 years at 14x. Your rollover potentially grows 40%+ on top of the platform's EBITDA growth.
How rollover can fail: The platform underperforms projections. They can't execute add-on acquisitions at target multiples. Interest rates stay high. When they eventually exit, it's at 8x-below what they paid you. Your rollover is worth less than you invested.
- Tag-along rights: You can sell when they sell
- Put options: Force them to buy your equity at predetermined terms
- Anti-dilution: Protection against future equity issuances
- Information rights: Quarterly financials and annual audits
- Board/observer seat: Visibility into major decisions
Earnouts in Physician Practice Sales
Earnouts are less common in physician deals than in other healthcare M&A, but they appear in approximately 40% of transactions. When they do, they're structured around:
- EBITDA targets: Maintain or grow profitability over 1-3 years
- Revenue targets: Hit collections thresholds
- Physician retention: Keep key physicians in practice
- Integration milestones: Complete systems transitions
The danger: PE buyers control operations post-close. They decide overhead allocations, billing practices, and staffing. If their decisions reduce your EBITDA, you miss earnout targets even if underlying performance is strong.
Employment Economics
Your employment agreement post-sale significantly impacts true economics. PE firms typically offer:
- Base salary: Often at or slightly below MGMA median for your specialty
- Production bonus: Percentage of collections above threshold
- Equity appreciation: Additional rollover grants for top performers
Calculate the difference between your current total compensation and the offered package. Over a 5-year employment commitment, a $100K annual reduction represents $500K in foregone income-which should factor into your valuation comparison.
Compare deals on "certainty-adjusted present value"-cash at close plus realistic earnout probability, minus the employment compensation haircut over your commitment period. A $15M mostly-cash deal often beats a $20M deal with 30% rollover and aggressive earnout targets.
The Letter of Intent: Where Physicians Lose Leverage
Letters of Intent for physician practice sales contain binding provisions (exclusivity for 90-120 days, confidentiality, expense allocation) and non-binding provisions (purchase price, rollover percentage, earnout structure, employment terms). Even non-binding terms create strong anchoring effects that are difficult to renegotiate after signing.
PE development teams are professional deal-makers. They've closed hundreds of physician practice acquisitions. They know exactly what language to use, what terms to bury, and how to create urgency.
Most physicians are signing their first (and possibly only) LOI. The information asymmetry is massive.
The PE LOI Playbook
- Create competition narrative: "We're looking at three other practices in your market. We need to move quickly to secure this opportunity."
- Lead with headline multiple: Present the highest defensible number. Bury earnout percentages, rollover requirements, and employment terms in later pages.
- Use "standard" language: "This is our standard LOI. We use the same terms across all our acquisitions." (Everything is negotiable.)
- Push for quick exclusivity: "Let's lock in exclusivity so we can start diligence. We can work out details in the definitive agreement."
Critical LOI Terms to Negotiate
Typically BINDING
- Exclusivity period (90-120 days)
- Confidentiality
- Expense allocation
- Governing law
- Break fee (if any)
Typically NON-BINDING
- Purchase price
- Rollover percentage
- Earnout structure
- Employment terms
- Closing conditions
The anchoring trap: Even "non-binding" terms create anchors. Once you've "agreed" to 30% rollover or a specific earnout structure, any attempt to improve terms will be characterized as bad faith renegotiation.
Understand what you're signing
Our LOI resources help physicians navigate the negotiation process:
PE buyers use urgency, "standard language," and attractive headlines to anchor negotiations early. Get M&A counsel involved before signing any LOI-the information asymmetry between their hundreds of deals and your one deal is the biggest risk to your proceeds.
Preparing for Due Diligence
Due diligence for physician practice sales spans 60-90 days and covers financial verification (quality of earnings, physician compensation vs. benchmarks, payor mix), compliance review (Stark Law, Anti-Kickback, billing practices, malpractice history), and operational assessment (physician retention risk, referral source analysis, IT systems). Findings frequently justify 5-15% purchase price reductions.
PE due diligence is comprehensive. They'll spend 60-90 days examining every aspect of your practice. What they find determines whether the price holds or gets renegotiated.
Due Diligence Focus Areas
Financial Due Diligence
- Quality of earnings analysis
- Revenue by payor and CPT code
- Physician compensation analysis vs. benchmarks
- Accounts receivable aging and collectability
- Working capital normalization
Compliance Due Diligence
- Billing and coding review
- Stark and Anti-Kickback compliance
- Licensure and credentialing status
- Malpractice claims history
- HIPAA compliance assessment
Operational Due Diligence
- Physician retention risk assessment
- Staff compensation and turnover
- Payor contract terms and expirations
- Referral source analysis
- IT systems and EHR review
Documents to Prepare
- 3 years tax returns (entity and physician K-1s)
- Monthly financial statements (24+ months)
- Physician employment agreements and compensation history
- All payor contracts
- Ancillary services documentation (ASC, imaging, lab)
- Real estate leases and ownership records
- Compliance program documentation
- Malpractice insurance policies and claims history
- All professional licenses and DEA registrations
Read our complete guide on what happens after you sign the LOI →
Run your own sell-side quality of earnings ($15-25K) and compliance review before going to market. Issues discovered during buyer diligence become price reductions; issues disclosed upfront are negotiation points you control.
Tax Planning and Employment Agreements
Tax implications for physician practice sales depend on entity structure (S-Corp vs C-Corp), purchase price allocation between tangible assets (depreciation recapture), covenant not to compete (ordinary income), and goodwill (capital gains). Stark Law and Anti-Kickback constrain post-sale physician compensation to fair market value, limiting certain deal structure options available in non-healthcare M&A.
Tax structuring in physician practice sales can shift 15-25% of net proceeds. The complexity increases when ancillary assets (ASCs, real estate) are involved.
Entity Considerations
Most physician practices are structured as S-corps, LLCs, or partnerships (pass-through entities). In asset sales, gains flow through to physician-owners' personal returns with different treatment for different asset classes:
- Tangible assets (equipment): Depreciation recapture at ordinary income rates
- Covenant not to compete: Ordinary income to seller
- Goodwill: Capital gains treatment (preferential rates)
The Stark/AKS Overlay
Unlike non-healthcare transactions, physician practice sales must comply with Stark Law and Anti-Kickback Statute. This constrains certain deal structures:
- Post-sale physician compensation must be at fair market value
- Can't structure deals where payment correlates to referral volume
- Purchase price allocation must be defensible under FMV analysis
Employment Agreement Economics
PE buyers typically offer employment agreements with:
- Term: 3-5 years
- Base compensation: MGMA median for specialty (50th-75th percentile)
- Productivity bonus: Usually based on wRVUs or collections above threshold
- Termination: "For cause" definitions are critical
If your current total compensation is $800K and the post-sale employment offer is $550K, that's $250K annual reduction. Over a 5-year commitment, that's $1.25M in foregone income. Factor this into your valuation analysis.
Calculate total economic impact by combining sale proceeds, after-tax treatment based on purchase price allocation, and the post-sale employment compensation reduction over your commitment period. A $250K annual salary reduction over 5 years represents $1.25M that should factor into comparing offers.
The Typical Sale Timeline
Physician practice sale timelines typically span 6-12 months: 1-2 months preparation, 2 months marketing, 1-2 months LOI negotiation, 3-4 months due diligence, and 1-2 months documentation/closing. Complex deals involving multiple ancillaries, real estate, or regulatory approvals can extend to 12-18 months.
Physician practice sales to PE typically take 6-12 months. Complex deals with multiple ancillary assets or regulatory approvals can extend longer.
Preparation
- Engage M&A counsel and advisors
- Prepare financial documentation
- Address compliance issues
- Develop confidential information memorandum
Marketing
- Confidential outreach to qualified buyers
- Management presentations
- Receive indications of interest
LOI Negotiation
- Receive and compare LOIs
- Negotiate key terms
- Execute LOI and begin exclusivity
Due Diligence
- Financial, legal, and compliance review
- Physician interviews
- Address findings and negotiate adjustments
Documentation and Closing
- Negotiate definitive agreements
- Finalize employment terms
- Obtain consents and approvals
- Close and fund
Download our detailed post-LOI milestone tracker →
Rushing the sale process costs money through worse terms and inadequate preparation. Build 1-2 months of preparation time before engaging buyers-cleaning up financials, addressing compliance issues, and assembling documentation proactively consistently yields better outcomes.
When to Engage M&A Counsel
Healthcare M&A counsel for physician practice sales costs $40,000-$100,000 depending on deal complexity, but typically recovers $200,000-$1,000,000+ through better deal structure, rollover equity protections, employment term optimization, and avoided regulatory pitfalls. The ROI comes from engaging before signing any LOI-after the LOI, negotiating leverage is significantly reduced.
Early. Before you sign anything. The typical mistake: waiting until the purchase agreement arrives.
By then, you've already agreed to LOI terms you don't fully understand. You've given exclusivity. You've mentally committed to a deal that may not be optimal.
What Healthcare M&A Counsel Does
Physician practice sales require attorneys who understand both M&A mechanics and healthcare regulatory constraints:
- Stark Law and Anti-Kickback compliance review
- PE deal structures and negotiation strategies
- Rollover equity terms and protection mechanisms
- Employment agreement optimization
- Coordination with tax advisors on structure
- Due diligence management
Engage healthcare M&A counsel before PE buyers approach you or before you sign anything. The $40-100K legal fee typically generates 5-10x ROI through better terms, rollover protections, and employment optimization that physicians can't recover after committing to a deal.
Practice Sale Assessment
Considering selling your medical practice? We'll review your situation, explain current PE valuations in your specialty, and help you understand your options-before you talk to buyers.
Request Engagement AssessmentFrequently Asked Questions
How much is my medical practice worth in 2026?
Medical practices sell for 3-15x EBITDA in 2026, depending on specialty, size, and ancillary services. Small primary care practices typically sell at 3-6x EBITDA. Specialty practices with owned ancillaries (ASCs, imaging, pathology) can command 10-15x from PE buyers. The median healthcare services multiple is approximately 11.5x, down from 14.5x in 2024.
Which medical specialties are private equity buying?
In 2026, the hottest specialties for PE acquisition include cardiology (fiercest competition), gastroenterology, ophthalmology (especially retina), dermatology, orthopedics, pain management, and urology. Practices with owned ancillary services like ASCs, imaging centers, or pathology labs command significant premiums-often adding 1-3 multiple turns.
What is rollover equity in a physician practice sale?
Rollover equity means keeping 15-40% of your sale proceeds invested in the acquiring platform rather than taking all cash. You become a minority shareholder. When the PE firm sells in 3-7 years, your rollover can multiply-or be worth less. PE firms use rollover to align incentives and demonstrate seller confidence in the combined entity's future.
How long does a physician need to stay after selling to private equity?
Most PE deals require physicians to commit for 3-5 years post-closing. Younger physicians under long-term employment contracts can receive 1-2x premium in valuation. The employment agreement terms-compensation, schedule, termination rights-should be negotiated during the LOI phase, not after.
Can I sell my practice if I don't own an ASC or ancillaries?
Yes, but expect lower multiples. Pure professional services practices without ancillaries typically sell for 3-8x EBITDA depending on specialty. PE buyers often acquire these practices intending to add ancillary services post-acquisition. The opportunity for the seller is negotiating rollover equity that benefits from the buyer's ancillary development.
What happens to my staff when I sell to PE?
Staff typically transition to the new entity. Compensation and benefits may change as the platform implements standardized packages. Key administrative staff sometimes negotiate retention bonuses. Clinical staff generally see minimal immediate changes, though reporting structures and operational protocols may evolve over time.
Ready to Explore Selling Your Practice?
Request a confidential engagement assessment to discuss your situation, understand current PE valuations in your specialty, and get clear guidance-before you talk to buyers.
Confidential. No obligation. We don't broker deals.